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     BSTRACT
In humans, electrical and contractile reverse remodelling following restoration of sinus 
rhythm (SR) after a prolonged period of spontaneous atrial fibrillation (AF), requires several 
weeks. There is little known about this phenomenon in horses. 
In the present study, six healthy horses were instrumented with a neurostimulator and a pace-
maker to maintain AF for four months by intermittent burst pacing and to study atrial and 
ventricular electrophysiology. AF became persistent in all horses after two to six weeks of burst 
pacing. Before, during and after the AF period, parameters, such as the atrial fibrillation cycle 
length, the right atrial and ventricular refractory period and vulnerability, such as inducing 
atrial arrythmias, atrial tachyarrythmias or maintaining AF, were determined. Two-dimensional 
echocardiography was used to measure atrial and ventricular contractility expressed as frac-
tional shortening and size expressed as diameter and area. 
In two of the six horses, the procedure was discontinued due to an increased threshold (1 
horse) and due to infection at the level of the pacemaker pocket (1 horse). In the four remaining 
horses, significant electrical and contractile remodelling compared to baseline values was ob-
served from 48 hours onwards after AF induction. Upon restoration of SR with quindine sulfate, 
all electrical and contractile values returned to normal within one to two months. No ventricular 
remodelling was observed. 
Four months of pacing-induced AF resulted in electrical and contractile remodelling and re-
verse remodelling. The results suggest that pacing-induced chronic AF does not cause permanent 
damage and suggest that a resting period of six to eight weeks before returning to training might 
be beneficial. 
SAMENVATTING
Na een langdurige periode van atriumfibrillatie neemt de elektrische en contractiele herstelperiode 
bij de mens meerdere weken in beslag. Momenteel is er maar weinig bekend over dit fenomeen bij het 
paard. 
In de voorliggende studie werden bij zes paarden een neurostimulator en een pacemaker ingepland 
om atriumfibrillatie (AF) te kunnen induceren en te onderhouden via een “burst-pacing”-mechanisme; 
en om de atriale en ventriculaire elektrofysiologie te kunnen bestuderen. Bij alle paarden ontstond 
persisterende AF na “burst pacing” gedurende twee tot vier weken. Parameters, zoals de atriale fibril- 
latiecyclus, de rechter atriale en ventriculaire refractaire periode en de gevoeligheid van het hart voor 
ritmestoornissen, zoals atriale aritmieën, atriale tachyaritmieën of AF, werden zowel voor en tijdens 
een AF-periode van vier maanden en gedurende een herstelperiode van twee maanden opgevolgd. De 
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INTRODUCTION
Atrial fibrillation (AF) is clinically the most impor-
tant supraventricular arrythmia in horses (Deem and 
Fregin, 1982; Reef et al., 1988; Reef and McGuirk, 
2002). AF can cause exercise intolerance, exercise-
induced epistaxis, respiratory disease, sudden weak-
ness, syncope or death due to ventricular dysrhyth-
mias, which can only be detected with an electrocar-
diogram (Deem and Fregin, 1982; Reef and McGuirk, 
2002, Verheyen et al., 2013). However, AF is often 
an incidental finding with no clinical complaints of 
performance loss that might already have existed for 
several weeks, months or potentially years.  
In the human literature, AF has been described as 
a self-promoting electrical disease due to electrical, 
contractile and structural remodelling. As a result, 
successful pharmacological or electrical treatment 
becomes more difficult the longer the AF lasts (Al-
lessie et al., 2002; Gold et al., 1986; Schotten et al., 
2003). With a neurostimulator, it is possible to induce 
AF in horses. With a pacemaker and ultrasound, it 
is possible to follow up the electrophysiological and 
contractile changes that appear during an AF period 
and during the recovery period (after restoration of 
sinus rhythm). Initially, it is necessary to frequently 
stimulate the atrium with a neurostimulator in order 
to maintain AF; however, after an unknown period of 
time, AF becomes persistent. A similar follow-up of 
electrophysiological and contractile remodelling and 
reverse remodelling of short-term AF (i.e. seven days) 
has already been described in healthy horses (De 
Clercq et al., 2008). In that study, significant atrial 
electrical and contractile remodelling were observed 
from four and twelve hours onwards, respectively. Af-
ter restoration of sinus rhythm (SR), reverse remodel-
ling was completed within two days. These data sug-
gest that early conversion of AF might be beneficial 
for the success rate, and that horses successfully trea-
ted for AF, only require a short resting period before 
returning to training. However, because many horses 
in clinical circumstances suffer from an AF duration 
of more than seven days, information about electrical 
and contractile remodelling and reverse remodelling 
after long-term AF is valuable. 
In this study, electrophysiological and two-dimen-
sional echocardiographic changes in the atrium and 
the ventricle during a four-month-period of induced 
AF were studied. In addition, the reversibility of the 
alterations was evaluated after permanent restoration 
of SR.  
MATERIALS AND METHODS
The study was performed at the Ghent University 
(Belgium) and was supported by the Special Research 
Fund, Ghent University (Belgium). This research was 
approved by the ethics committee of the Faculty Vete-
rinary Medicine, Ghent University (Belgium) (ECnr: 
200235).
Animal and study protocol
Six healthy, untrained trotter horses with a mean 
age of 4.6±0.5 years, a mean weight of 485±24 kg 
and a mean height at the withers of 156±5 cm, were 
included in the study. Clinical examination, electro-
cardiography and echocardiography, including two-
dimensional, M-mode and Color flow Doppler, were 
performed by an equine internal medicine specialist 
with advanced skills in cardiology (DDC) to exclude 
underlying heart disease.
In all horses, a dual chamber pacemaker (Thera 
D(R), Medtronic, Minneapolis, MN) and a neurosti-
mulator (Soletra 7426, Medtronic) were implanted, 
and an induced AF period was started as previously 
described to determine electrophysiological parame-
ters before the AF period (thus in SR), during the AF 
period of four months and during the recovery period 
in SR (van Loon et al., 2001 and 2002; De Clercq et 
al., 2008). All horses were treated with quinidine sul-
fate for cardioversion to SR. 
With the neurostimulator, intermittent burst pacing 
(three times threshold, 20 Hz, every two seconds) was 
performed until AF was induced. The dual chamber 
pacemaker allowed studying atrial and ventricular 
electrophysiology.
The study consisted of three periods: a baseline 
period (for the determination of the baseline values 
atriale en ventriculaire contractiliteit uitgedrukt in fractionele “shortening” en de grootte van de hart-
compartimenten werden opgevolgd via 2D-echocardiografie. 
Bij twee van de zes paarden kon de procedure niet volledig opgevolgd worden ten gevolge van te 
hoge drempelwaarden (1 paard) of door een infectie ter hoogte van de “pocket” (1 paard). Bij de andere 
vier paarden konden er reeds na 48 uur van AF significante verschillen gemeten worden ten opzichte 
van de basale waarden. Tijdens de herstelperiode keerden alle waarden na één tot twee maanden naar 
de basale waarden terug. 
In dit onderzoek wordt aangetoond dat geïnduceerde chronische AF, elektrische en contractiele 
veranderingen teweegbrengt ter hoogte van het hart bij het paard maar dat deze veranderingen omkeer-
baar zijn eens het sinusritme hersteld is. Deze resultaten suggereren dat er geen permanente schade 
veroorzaakt wordt door vier maanden pacing-geïnduceerde AF en dat een rustperiode van zes tot acht 
weken gunstig zou zijn alvorens het werk te hervatten.
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(Figures 1, 2 and Tables 2, 3), a four-month AF period 
and a two-month recovery period. An overview of the 
timing of all measurements during the different peri-
ods is given in Table 1. The measured values can be 
found in Tables 2 and 3 and in Figures 1 and 2. Mea-
surements during the baseline period were repeated 
on five different days to obtain a mean value. Dur-
ing the AF period, electrophysiological and echocar-
diographic measurements were performed in AF and 
within twenty minutes after spontaneous restoration 
of SR. When SR did not restore spontaneously, ven-
tricular effective refractory period (VERP) and echo-
cardiographic measurements were only performed in 
AF as atrial effective refractory period (AERP) can 
only be determined during SR. AF became persistent 
after two (horse 1 and 3), four (horse 2) and six weeks 
(horse 4). From the moment all echocardiographic 
and/or electrophysiological measurements were ob-
tained in SR, the pulse generator was immediately 
switched on again for further maintenance of AF. Af-
ter a certain period of time, AF was self-entertained 
and was thus persistent at the end of the four-month 
AF period, as in all horses. Subsequently, a pharmaco-
logical cardioversion with quinidine sulfate (QS) by a 
nasogastric tube (22mg/kg every 2 hours) was neces- 
sary to perform the next step of the study (i.e. the fol-
low-up after restoration of sinus rhythm). The total 
cumulative dose of QS administered in a two-hour in-
crements necessary to convert to SR ranged between 
22 - 66 mg/kg. 
Electrophysiological measurements
A programmed electrical stimulation test was per-
formed in the atrium and the ventricle at three times 
baseline threshold amplitude for stimulation. During 
pacing with a fixed pacing interval (S1-S1), an extra 
stimulus (S2) was introduced with a coupling inter-
val (S1-S2) below the expected refractory period. 
The coupling interval was then prolonged in steps of 
8 ms until capture of the extra stimulus occurred, i.e 
the atrial or ventricular S2 was followed by a P wave 
or QRS complex on the surface base-apex ECG, res-
pectively. The longest S1-S2 interval without capture 
in the atrium or the ventricle was taken as AERP or 
VERP. As AERP changes with heart frequency, it was 
measured at pacing cycle lengths (PCL) of 1000 ms 
(60 beats/min), 800 ms (75 beats/min), 500 ms (120 
beats/min) and 333 ms (180 beats/min). VERP was 
also measured at PCL of 1000, 800 and 500 ms. Two 
minutes of basic pacing was performed before starting 
to measure ERP (van Loon et al., 2002, De Clercq et 
al., 2008). At each PCL, AERP and VERP were deter-
mined three times to obtain a mean value. The atrial 
fibrillation cycle length (AFCL) was measured as the 
average time between two successive atrial depolari-
zations on a ten-second-intra-atrial electrogram. 
The presence of arrythmias during the AF induc-
tion period was evaluated via a standard base-apex 
electrocardiogram.
Figure 2. Left atrial fractional shortenings (FS%) 
(mean±SD) measured from the left (LLA-FS%) and from 
the right (LA-FS%) echocardiographic view and frac-
tional area change (FAC%) at baseline during the AF 
period (light grey) and during recovery time (dark grey).
 *= significantly different compared to baseline.
Figure 1. Mean (±SD) atrial fibrillation cycle length 
(AFCL;-∆-) and heart rate (HR; -■-) at baseline, dur-
ing the AF period (light grey) and during recovery time 
(dark grey) in four horses. 
QS: treatment with quinidine sulfate. *=AFCL signifi-
cantly different compared to the first AFCL measure-
ment in the AF period (p<0.05), °= significantly differ-
ent compared to baseline measurement (p<0.05).
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Echocardiographic views and measurements
Echocardiographic views were obtained using stan- 
dardized imaging techniques with a 2.5 MHz sector 
transducer at a depth of 30 cm (GE Vingmed CFM 
800 SV). A single-lead electrocardiogram was recor-
ded simultaneously. Recordings were stored digitally 
and on video tape for retrospective analysis.
Every echocardiographic variable was determined 
from five cardiac cycles to obtain a mean value. Mea-
surements were performed in SR at baseline, during 
the AF period (if SR restored spontaneously), and du-
ring the recovery period (in SR). Cycles during and 
immediately after a second-degree atrioventricular 
block or a spontaneous atrial premature beat were ex-
cluded from analysis. During the AF period, measu-
rements were performed in AF. Measurements were 
performed at an RR interval between 1333 to 1090 
ms (or a heart frequency between 45 to 55 beats/min). 
This is the heart rate that is most frequently seen in 
horses with spontaneous AF.
Left atrial dimensions were measured on a left 
parasternal view and a right parasternal long-axis 
view. Left atrial inner diameter was measured on a 
left parasternal view close to the annulus of the mitral 
valve (L-LAD). On a right parasternal long-axis view, 
internal diameters were measured from the interatrial 
septum, close to the mitral annulus, to the atrial free 
wall (R-LAD). In the same view, a cross-sectional area 
(R-LAA) was measured (De Clercq et al., 2008). For 
every cardiac cycle, four-time points were determined 
to perform all these measurements: point “p” was at 
the onset of the P wave; point “a” was during maximal 
atrial contraction indicated by smallest atrial volume, 
point “d” was at the end of the ventricular diastole at 
the moment the mitral valve had just been closed, and 
point “s” was at the end of ventricular systole. Due 
to the absence of a P wave and an atrial contraction, 
points “p” and “a” could not be determined during AF.
Left atrial fractional shortening (LA-FS%) and left 
atrial fractional change (LA-FAC%) were calculated 
as follows (Piotrowski et al., 2000): 
Table 1. Overview of the timing of all measurements during the different periods. AF period is represented in light 
green and the recovery time period in dark green.
 Baseline 2d 1w 2w 4w 6w 4m After 1d 3d 5d 1w 2w 3w 1m 1.5m 2m
        QS 
Heart rhythm + + + + + + + + + + + + + + + + +
Heart rate + + + + + + + + + + + + + + + + +
AFCL  + + + + + +
AERP +  +    + + + + + + + + + +
Echocardiography + + +    + + + + + + + + + +
QS: quinidine sulfate
d: days, w: weeks, m: months
Table 2. Mean (±SD) atrial effective refractory period (AERP) at pacing cycle length of 1000, 800, 500 and 333 ms and 
ventricular refractory period (VERP) at pacing cycle length of 1000, 800 and 500 ms during the AF period (light green) 
and during the recovery time period (dark green) in four horses. 
 
 ERP 1000 AERP 800 AERP 500 AERP 333 VERP 1000 VERP 800 VERP 500
Baseline 256±22 254±24 249±28 226±23 358±11 322±15 251±18
2d 185±37* 184±38* 193±32* 182±27* 400±35* 349±41 258±45
1w 163±23* 168±21* 171±24* 165±28* 374±31 333±24 253±14
After QS 219±16* 225±30 248±30 148±08* 388±35 372±33* 276±36
1d 241±13 249±10 243±05 224±09 401±21* 346±14 251±19
3d 243±21 247±14 239±06 205±07 395±26* 355±13* 266±10
5d 250±21 251±17 245±07 208±10 395±21* 354±09 268±08
1w 248±13 246±14 242±07 206±07 383±30 345±23 262±21
2w 257±16 255±11 245±12 212±09 396±24* 365±20* 265±09
3w 255±14 255±07 241±11 214±13 395±20* 353±18 259±12
1m 255±21 255±18 245±16 209±15 404±12* 356±13* 262±13
1.5m 264±13 260±07 255±09 215±09 392±16* 353±20 265±18
2m 260±15 259±14 246±17 214±13 390±23* 351±13 261±08
QS: quinidine sulfate
* = significantly different from baseline (p<0.05)
d: days, w: weeks, m: months
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On a standard M-mode of the ventricles, the left 
ventricular internal diameter, the interventricular sep-
tal thickness and the left ventricular free wall thick-
ness were measured in diastole and systole; and the 
left ventricular fractional shortening was calculated. 
Color flow Doppler examinations of the mitral, tricus-
pid, aortic and pulmonic valves were performed. All 
ECG recordings were performed with the electrodes 
in a standard base apex position for horses. No cardiac 
enzyme activity was followed during this study.
Statistical analysis
Data are shown as mean ± standard deviation. 
First, a linear mixed model (univariate analysis of 
variance) was applied with ‘horse’ as random effect 
and ‘time’ as categorical fixed effect, at a significance 
level of 5%. If the effect of time was significant, a 
post hoc Dunnett’s test was performed to compare all 
time points to the baseline value at time zero to adjust 
for multiple comparisons, at a significance level of 
5%. Heart rate and echocardiographic measurements 
of LA dimensions in SR and in AF were compared 
using a linear mixed model with ‘time’ and ‘rhythm’ 
(SR or AF) as fixed factors and ‘horse’ as the unit of 
repeated measure.
RESULTS
After pacemaker implantation, two horses were 
excluded from the study protocol due to an increased 
threshold of the pacemaker lead; this lead was used 
for the electrophysiological measurements (1 horse), 
and one due to infection at the level of the pacemaker 
pocket (1 horse). In the first case, the pacemaker and 
the leads were removed; in the second case, the pace-
maker leads and the pacemakers were removed and an 
antimicrobial treatment was started. Both horses reco-
vered success-fully. In the other four horses, AF could 
be success-fully induced and maintained using the 
intermittent burst pacing protocol. AF became persi-
stent after two (horses 1 and 3), four (horse 2) and 
six weeks (horse 4) of maintenance by burst pacing; 
thus, the horses became vulnerable for AF over time. 
All horses were successfully converted to SR after a 
total of two or three doses of QS at a two-hours’ inter-
val. One horse (horse 2) showed widening of the QRS 
complex and tachycardia after the second dose of QS. 
In two horses (horse 1 and 4), an electrocardiogram 
showed that atrial premature complexes were present 
until three weeks after restoration of SR. 
Electrophysiological measurements
Except for horse 2, atrial programmed electri-
cal stimulation could be performed according to the 
predefined protocol. In horse 2, atrial threshold had 
risen above the maximum output levels of the pace-
maker when SR was restored after four months of 
AF. There-fore, in horse 2, electrical measurements 
during the recovery period were performed with a 
temporary pacing catheter (Bipolar Intracardiac Elec-
trode, USCI) using the same pacing protocol. In all 
Table 3. Mean (±SD) echocardiographic measurements before, during the AF period (light green), and after restoration 
to sinus rhythm (dark green). L-LAD: left atrial diameter measured from a left parasternal long-axis view. R-LAD: 
left atrial diameter measured from a right parasternal long-axis view. R-LAA: left atrial area measured from a right 
parasternal long-axis view. d: end ventricular diastole, s: end ventricular systole. 
 Left  Left Right Right Right Right  
 parasternal parasternal parasternal parasternal parasternal parasternal 
 long-axis long-axis long-axis long-axis long-axis long-axis 
 view view view view view view 
 LLADd LLADs LADd LADs LAAd LAAs
Baseline 9.1±0.3 10.4±0.4 8.8±0.5 9.7±0.6 41.4±6.7 55.1±5.8
2d 8.2±0.9 9.9±0.8 8.4±0.8 8.7±0.8* 41.1±9.8 45.3±7.6*
1w 9.0±0.9 10.0±0.8 8.3±0.9 8.7±0.9* 41.2±8.5 45.7±6.7*
Just after QS 9.8±1.0* 10.6±0.8 9.1±0.9 9.8±0.8 50.0±11.6* 58.93±10.6
1d 9.5±0.8 10.5±0.7 9.3±1.0 10.0±0.9 49.3±10.5 59.7±10.6
3d 9.5±0.8 10.5±0.7 9.3±0.9 9.9±0.9 49.3±10.5 59.7±10.6
5d 9.4±0.7 10.4±0.7 8.9±0.7 9.5±0.8 47.3±7.2 57.2±8.6
1w 8.9±0.6 10.2±0.7 8.6±0.5 9.6±0.7 46.1±8.0 55.1±6.9
2w 9.1±1.0 10.4±1.1 8.6±0.7 9.6±0.9 43.86±6.9 55.1±8.8
3w 9.1±1.2 10.3±0.7 8.4±0.8 9.2±1.0 43.4±8.8 52.5±8.8
1m 8.9±0.9 10.2±0.7 8.5±0.7 9.4±0.9 42.7±6.5 53.4±5.3
1.5m 9.0±0.8 10.1±0.9 8.4±0.8 9.4±0.7 42.5±7.6 53.7±9.5
2m 9.0±0.9 10.1±0.8 8.5±0.8 9.24±0.9 41.6±9.2 53.6±9.2
QS: quinidine sulfate
* significantly different from baseline (p<0.05). 
d: days, w: weeks, m: months
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horses the threshold of the ventricular lead increased 
slightly during the AF period, which resulted in bor-
derline stimulations (just below three times baseline 
threshold) during the ventricular programmed electri-
cal stimulation studies.
Atrial fibrillation
After one day of maintained AF, the mean AFCL 
of the four horses was 243±13ms and decreased to 
151±15 ms after four months of AF. From two days 
onwards, there was a significant decrease of AFCL 
(Figure 1). A significantly increased heart rate was 
only observed during the first week of AF and on the 
day of quinidine treatment (Figure 1). There was no 
significant difference between the heart rate measured 
at the same time point in SR or in AF during the AF 
period (data not visible).
Atrial electrophysiology
At baseline, AERP was 256±22 ms, 254±24 ms, 
249±28 ms and 226±23 ms at a pacing CL of 1000, 
800, 500 and 333 ms, respectively. After one week 
of maintained AF, AERP had shortened significantly 
(Table 2). Quinidine treatment resulted in an im-
mediate significant increase of AERP. One day was 
necessary to achieve AERP baseline values after the 
pharmacological treatment (Table 2). Shortening of 
AERP (during the AF-period) was associated with 
atrial premature beats, atrial tachycardia or a period 
of short-term AF. The presence of atrial premature 
beats, atrial tachyarrythmias or short-term AF varied 
per individual horse.
Ventricular electrophysiology
At baseline, VERP was 358±11 ms, 322±15 ms 
and 251±18 ms for a CL of 1000, 800 and 500 ms, 
respectively (Table 2). A significant increase of VERP 
for a CL of 1000 and 800 occurred during the recove-
ry period. VERP measurements were never associated 
with ventricle tachycardia or ventricle fibrillation. 
Echocardiographic measurements
Four months of AF did not result in a significant 
increase of R-LADd, L-LADd, R-LADs, L-LADs, R-
LAAd and R-LAAs.  
R-LA-FS%, L-LA-FS% and R-LA-FAC% had 
already decreased significantly within two days of 
maintained AF (p<0.0001). After one week of AF, the 
atrial contractile function was almost completely ab-
sent. Values recovered within one to two months of 
restoration of SR (Figure 2).
The left atrial sizes measured during AF were 
comparable with the sizes measured in SR at the com-
parable time point (only measurements performed du-
ring AF are given in Table 3).
No significant changes were observed in inter-
ventricular septal thickness, left ventricular free wall 
thickness, left ventricular internal diameters nor in left 
ventricular fractional shortening throughout the study. 
Color flow Doppler of all valves revealed no differen-
ces compared to baseline (there were no pathological 
valvular regurgations present before, during or after 
the study).
DISCUSSION
In the present study, electrical and contractile re-
modelling was evaluated during an artificially indu-
ced chronic AF model in horses. The major findings 
of this study were: (1) pacing-induced AF resulted in 
atrial electrical and contractile remodelling; (2) AFCL 
decreased significantly during the first fourteen days 
of AF and remained significantly lower throughout 
the AF period; (3) two-dimensional ultrasound did not 
allow to demonstrate significant differences in atrial 
size; (4) electrical reverse remodelling after pharma-
cological conversion of sinus rhythm appeared faster 
than contractile reverse remodelling. 
Horses with naturally occurring AF are frequently 
presented with subacute (two weeks) or chronic AF. 
In addition, these horses are commonly classified as 
‘lone’ fibrillators, because echocardiography reveals 
no or only clinically non-relevant abnormalities. The 
purpose of the present study was to examine ‘lone’ AF 
in horses. Therefore, young and healthy horses were 
selected without abnormalities on clinical examina-
tion, electrocardiography at rest and during exercise 
and echocardiography including two-dimensional 
ultrasound, M-mode and Color flow Doppler. Clini-
cal examination, electrocardiography during rest and 
exercise and echocardiography was performed by an 
equine internal medicine specialist with advanced 
skills in cardiology (DDC). 
The burst pacing protocol was effective to induce 
and maintain AF in four out of six horses (two horses 
were left out of the study due to increased threshold 
and infection of the pacemaker pocket) even though 
two of the four remaining horses needed a period of 
pacing (horse 2: four weeks; horse 4: six weeks) be-
fore AF became persistent. Besides the measurements 
made during AF, brief periods of spontaneously resto-
red SR allowed to make electrophysio-logical measu-
rements during normal SR during the first eight days 
of the protocol in all horses without any administra-
tion of drugs. However, persistent AF appeared after 
8, 28, 10 and 42 days for horse 1, 2, 3 and 4, respecti-
vely. The progressive increase in susceptibility for AF 
has also been shown in experimentally induced atrial 
fibrillation in ponies, goats and dogs (Morillo et al., 
1995; Wijffels et al., 1995; van Loon et al., 2001). In 
the study by Morillo et al. (1995), a six-weeks’ episo-
de of rapid atrial pacing induced AF lasting for more 
than 15 minutes in 82% of the studied dogs; while 
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in a study by van Loon et al. (2002), six months of 
burst pacing resulted in persistent AF in only one of 
four research ponies. The fact that horses have more 
tendency to fibrillate than small animals, i.e. dogs, po-
nies, can be explained, at least in part, because horses 
have a larger atrial size. This explains why naturally 
occurring AF is more frequently encountered in hor-
ses than in ponies (Else and Holmes, 1971; Bertone 
and Wingfield, 1987; Detweiler, 1989). The old mul-
tiple wavelet re-entry theory of Moe (1962) partially 
explains why AF has more tendency to persists in 
larger atria. In this theory, Moe (1962) described that 
the presence of AF is dependent on the possibility of 
the atrium to maintain a critical number of re-entry 
circuits. The development therefore depends on the 
atrial diameter and the size of the re-entry circuits. 
This re-entry circuit size is expressed as the wave-
length (WL) of re-entrant circuits and is defined by 
the AERP and conduction velocity (CV)(WL=AERP 
X CV). AF develops more easily if the atrial diameter 
is larger and/or the wavelength is shorter; thus, if the 
AERP or the CV decreases.
In humans and dogs, AF is characterized by a rapid 
and irregular ventricular response. However, during 
atrial flutter, which is accompanied by a slower atrial 
rate, a higher ventricular response is often seen since 
more atrial impulses are transmitted to the ventricles 
probably due to less concealed conduction at the atrio-
ventricular node (Hnatkova et al., 1998; Miller et al., 
1999; King et al., 2002; Silbauer and Sulke, 2007). 
In the horses of the present study, only a significant 
increased heart rate during the first week of AF was 
observed.
The decrease in AFCL might be explained by an 
increase in the number of wavelets due to the shorte-
ning of the AERP with the increasing duration of AF 
(Moe, 1962).
In the horses of the present study, a significant in-
crease in VERP during the AF period and during the 
recovery period was observed. During the study, there 
was a small increased threshold of the ventricular 
lead, whereby maximal pacemaker output was needed 
to reach three times threshold amplitude. This tech-
nical limitation might, in part, explain the increased 
VERP since borderline or submaximal power can af-
fect VERP values.
A shortening of AERP and a reduction of atrial 
contractility during the first hours and days of AF 
induction has been observed in dogs, goats, horses 
and humans (Olsson et al., 1971; Cotoi et al., 1972; 
Wijffels et al., 1995; Franz et al., 1997; Schotten and 
Allessie, 2001; Allessie et al., 2002; Schotten et al., 
2003; Schwarzwald et al., 2007, Thanigaimani et al., 
2017). In an AF-induced model in goats, a new steady 
state of atrial refractory period appeared after two to 
three days and atrial contractile function was almost 
completely lost after two days (Wijffels et al., 1995). 
This shortening of AERP leads to an increased vulner-
ability for AF, which can eventually lead to persistent 
AF (Wijffels et al., 1995). In a study by Allessie et al., 
(2002), reverse electrical remodelling was still com-
pletely reversible in goats after months or even years 
of AF. It took only a few days for AERP to become 
normal again after seven weeks of AF (Allessie et al., 
2002). After a six-week AF period, atrial contractile 
function was recovered one month after conversion in 
human patients (Manning et al., 1994). Similar changes 
were observed during the present study in horses.
The occurrence of atrial premature beats after 
conversion, as observed in the horses of the present 
study, has also been described in humans (Maounis 
et al., 2001) and is also observed in some horses who 
were treated for naturally occurring AF. The patho-
physiology of electrical and contractile remodelling 
is quite complex and is only partly understood, but 
calcium levels and the sensitivity of calcium chan-
nels to calcium play a major role. Atrial tachycardia 
induces intracellular calcium overload followed by a 
downregulation of the L-type calcium channels and a 
subsequent reduction of sarcolemmal calcium influx. 
This eventually results in a shortening of the AERP or 
a loss of the plateau phase of the action potential (Yue 
et al., 1997; Yue et al., 1999). 
The short refractory period results in a reduction of 
wavelength, which increases the vulnerability for AF. 
However, this could not explain the subsequent de-
creased efficacy of cardioversion and maintenance of 
SR in chronically instrumented goats with prolonged 
AF duration, because atrial remodelling appears rather 
quickly (Wijffels et al., 1995). Possibly, one or more 
other factors may be involved in the increase in vul-
nerability for AF. One of these factors is loss of the 
atrial contractile function (Tieleman and Crijns, 2000; 
Thanigaimani et al., 2017; Thomas and Abhayaratna, 
2017). In humans, this process also occurs due to 
alterations in cellular calcium handling (Sun et al., 
1998). In addition, this contractile dysfunction may 
lead to atrial paralysis and an increase in compliance 
of the atria. Subsequently, this may cause dilatation 
of the atria during the course of several days to weeks 
of AF (Schotten and Allessie, 2001; Thomas and 
Abhayaratna, 2017). In the four horses of the pres-
ent study, a rapid decline of AERP and a loss of atrial 
contractile function with an increase in vulnerability 
were also observed. In the artificial AF model used in 
the present study, the increase in atrial size was not 
significant in the four horses. AF became persistent in 
each horse necessitating cardioversion. 
In humans, atrial contractile dysfunction has been 
suggested to delay the improvement in exercise in-
tolerance after cardioversion, and may influence the 
recurrence of AF (Harjai et al., 1997; Khan, 2003; 
Schotten et al., 2003). It is not known whether this 
delay in exercise intolerance also applies for horses. 
However, in a study in horses with naturally occur-
ring chronic AF (1.5-24 months), the atrial contractile 
function was restored seven weeks after conversion, 
although the atrial dimensions were still increased 
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compared to the reference values of normal horses 
(Decloedt et al., 2013).
LIMITATIONS OF THE STUDY
In this preliminary study, two of the six horses 
could not complete the study due to technical pro-
blems. Therefore, the results regard a very small study 
population. In addition, the study was not blinded and 
a control group was absent.
CONCLUSION
The results of this study indicate that, in the four 
healthy horses, experimentally induced AF brings 
about rapid electrophysiological and contractile re-
modelling. In each horse, self-entertaining and thus 
persistent AF appeared after one to six weeks of in-
termittent burst pacing. After pharmacological resto-
ration to SR, rapid electrical reverse remodelling and 
a slower normalization of atrial contractility were ob-
served within a few weeks. This study indicates that 
induced chronic, pacing-induced AF does not suggest 
permanent electrical alterations and that reverse re-
modelling is still possible after a chronic, pacing-in-
duced AF period of four months.
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